Researchers find key to clearing precancerous cells, and with it, a potential treatment mechanism
17 January 2024
Researchers have chipped away a little more at the mystery of cancer resistance, this time in the form of new findings that explain how the immune system senses DNA damage in precancerous cells.
Spectroscopy milestone signals advance in protein imaging
17 January 2024
An ultra-high sensitivity and super-resolution infrared imaging technique for single proteins could lead the way to a multitude of applications using infrared nanospectroscopy.
Achieving optimal advanced process control in bioproduction
16 January 2024
Model Predictive Control (MPC) “stands out as a beacon of advanced control” in continuous manufacturing, through its ability to enhance efficacy within bioproduction, research suggests.
FDA clears AI that predicts Alzheimer’s progression from an MRI scan
16 January 2024
The FDA has granted a de novo clearance to an artificial intelligence program capable of reading a standard brain MRI scan and predicting a patient’s chances of progressing from mild cognitive impairment and early memory loss to Alzheimer’s disease and dementia within five years, according to the software’s developer Darmiyan.
Vaccine demonstrates benefit in delaying cancer relapse
15 January 2024
Data from the Phase I trial showed that the cancer vaccine offered an 86 percent reduction in the risk of relapse or death in pancreatic and colorectal cancers.
New collaboration could transform neonatal therapy
12 January 2024
With no currently approved medicines for the prevention of bronchopulmonary dysplasia (BPD) in extremely pre-term infants, a new pharmaceutical collaboration could produce the first major therapeutic breakthrough for this patient group in decades.
Pharmacovigilance Industry Survey Report for 2023: Trends on Transformation
12 January 2024
In the dynamic realm of healthcare, ensuring drug safety stands as an absolute priority for life sciences companies. To understand more about the intricate landscape of Pharmacovigilance (PV), Indegene embarked on a journey and delved deep into current practices, unveiling the challenges that PV professionals are determined to conquer, exploring how diverse organizations harness the power of technology, and catching a glimpse of the future.
Russia actively participates in WHO decisions
11 January 2024
World Health Organization representative Melita Vujnovic, who wraps up her mission to Russia, believes that the world will become better in 2024, and diplomacy will prevail. “I hope that the world will become better in 2024. I am an irredeemable optimist. And I hope that diplomacy will once again be able to speak louder than something else,” she told TASS.
Moscow has implemented three standards for the use of AI in medicine
11 January 2024
Three initial standards for the secure implementation of artificial intelligence (AI) in the field of medicine were enforced in Moscow on January 1, 2024. They will be in effect for three years, said the capital’s mayor Sergei Sobyanin.
Positive data from schizophrenia clinical trials revealed
10 January 2024
Newron Pharmaceuticals and Lyndra Therapeutics’ have announced positive data from key clinical trials in schizophrenia and schizoaffective disorder.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024